IL36G and psoriasis: IL-38 was shown to regulate keratinocyte differentiation and was proposed as an anti-inflammatory mediator during psoriasis, preventing the induction of IL-36γ-mediated pro-inflammatory responses in human keratinocytes in vitro and reducing the severity of inflammation, when injected into mouse skin in vivo (7, 11).